(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

weight loss programs

Most weight loss drug users quit before seeing benefits

May 22, 2024 A majority of patients taking weight loss drugs discontinue use of their medication before reaching a clinically meaningful health benefit, according to new research published May 21 by the Blue Cross Blue Shield Association. The study was conducted by Blue Health Intelligence and is based on national pharmacy and medical claims data from […]

Most weight loss drug users quit before seeing benefits Read More »

Medifast To Launch National Marketing Campaign

May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed

Medifast To Launch National Marketing Campaign Read More »

How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast

May 9, 2024 John LaRosa, Marketdata’s Research Director and founder, was recently interviewed by Kimberly Adams at Marketplace, a business and economic program, along with several others, about how the weight loss market is changing currently, being affected by the hugely popular GLP-1 weight loss medications. Here’s the interview, on audio. Click this link to

How GLP-1 Drugs Are Changing The Weight Loss Market – Podcast Read More »

Medifast Reports Q1 2024 Results

April 29, 2024 Management said that: “Our new model is highly differentiated from competitors, with a holistic approach including our habit-based and Coach guided solution along with nutrition products and community support. It will be supported by a reimagined framework for customer acquisition, with a new company-led national marketing campaign, enhancing both awareness of the

Medifast Reports Q1 2024 Results Read More »

Higher Quality Weight Loss Drugs Coming in the Future

April 29, 2024 According to an article at Biospace.com, GLP-1 agonists are set to become the best-selling drugs in 2024, but the biopharma industry isn’t resting on its collective laurels. Instead, some companies are pushing to improve upon the popular obesity medicines with therapies that promote higher-quality weight loss. Clinical studies have shown that up

Higher Quality Weight Loss Drugs Coming in the Future Read More »

Eli Lilly Offers Access To Zepbound via Amazon

March 14, 2024 The U.S. pharmaceutical giant Eli Lilly is partnering with Amazon to help distribute its prescription drugs, notably its new weight loss treatment called Zepbound. Eli Lilly is using Amazon Pharmacy to distribute Zepbound to people’s homes through the drug maker’s new direct-to-consumer program. Going forward, Amazon Pharmacy will deliver drugs from Eli

Eli Lilly Offers Access To Zepbound via Amazon Read More »

Scroll to Top